| scholarly article | Q13442814 |
| P2093 | author name string | J Schrader | |
| L C Hofbauer | |||
| M Schoppet | |||
| D Hörsch | |||
| U Niebergall | |||
| H Jahr | |||
| M D Brendel | |||
| W Rennekamp | |||
| P2860 | cites work | Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation | Q24681552 |
| TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction | Q28218216 | ||
| Islet transplantation as a treatment for diabetes - a work in progress | Q28244953 | ||
| Osteoprotegerin ligand: a regulator of immune responses and bone physiology. | Q34079327 | ||
| Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | Q34469691 | ||
| A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis | Q34495385 | ||
| Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland | Q40706650 | ||
| International trial of the Edmonton protocol for islet transplantation. | Q54032399 | ||
| Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells | Q56453539 | ||
| Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays | Q73831600 | ||
| Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis | Q73935898 | ||
| P433 | issue | 6 | |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 1243-1247 | |
| P577 | publication date | 2007-04-19 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death | |
| P478 | volume | 50 |
| Q59326110 | Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines |
| Q35907078 | Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis |
| Q48265392 | ERK5 plays an essential role in gestational beta-cell proliferation |
| Q93093562 | How, When, and Where Do Human β-Cells Regenerate? |
| Q36530849 | Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice |
| Q41583592 | Mesenteric lymph duct drainage attenuates acute lung injury in rats with severe intraperitoneal infection |
| Q52689330 | Modeling human pancreatic beta cell dedifferentiation. |
| Q38190197 | Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus |
| Q38951158 | Novel factors modulating human β-cell proliferation |
| Q35890262 | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion |
| Q36135658 | Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway |
| Q34229800 | Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes |
| Q92618416 | Osteoprotegerin promotes islet β cell proliferation in intrauterine growth retardation rats through the PI3K/AKT/FoxO1 pathway |
| Q35224888 | Prolactin receptors and placental lactogen drive male mouse pancreatic islets to pregnancy-related mRNA changes |
| Q37369774 | The transcriptional response of the islet to pregnancy in mice |
Search more.